PFIZER, INC. |
Market Closed -
Other stock markets
|
Pre-market 06:08:41 pm | |||
| 26.98 USD | -2.00% |
|
26.94 | -0.17% |
| 01:18pm | Pfizer Sued by Kansas Over Covid-19 Vaccine | MT |
| 12:00am | Certain Ordinary Shares of Haleon plc are subject to a Lock-Up Agreement Ending on 18-JUN-2024. | CI |
Presenter SpeechChris Shibutani (Analysts)Okay. Let's kick off our discussion with Pfizer here...
This article is reserved for subscribers To unlock the article, SUBSCRIBE!
Already a customer? Log In
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows:
- primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.;
- specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.;
- oncology products (12.1%);
- other (1.3%).
At the end of 2022, the group had more than 35 manufacturing sites worldwide.
Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
Pharmaceuticals
Calendar
30/07/2024
- Q2 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
26.98
USD
Average target price
31.92
USD
Spread / Average Target
+18.29%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -6.29% | 153B | |
| +51.82% | 797B | |
| +40.57% | 628B | |
| -6.88% | 351B | |
| +16.95% | 323B | |
| +9.49% | 300B | |
| +17.00% | 244B | |
| +0.94% | 223B | |
| +5.30% | 163B | |
| -2.18% | 118B |
- Stock Market
- Equities
- PFE Stock
- News Pfizer, Inc.
- Transcript : Pfizer Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-10-2024 11
